Save time and get answers to complex questions with AI chat
Pramlintide approval date?Allergan's patent for latisse expired?Xenazine current manufacturer 2025?Patent tenofovir alafenamide gilead?Mebendazole ingredients?
See the DrugPatentWatch profile for Xeljanz
Xeljanz is the brand name for tofacitinib (a Janus kinase, or JAK, inhibitor). [1]
No. When people refer to a “Xeljanz generic,” they typically mean tofacitinib (marketed in different forms/dosages), not a different active ingredient. [1]
DrugPatentWatch lists the product under tofacitinib for Xeljanz-related patent and market research. [1]
1
Other Questions About Xeljanz :